Onset of Graves' disease during pregnancy in a woman with established hypothyroidism. 2017

María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
a Servicio de Endocrinología y Nutrición, Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria, Instituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria , Las Palmas de Gran Canaria , Spain.

BACKGROUND Pregnancy strongly influences the thyroid gland and its function. Thyroid guidelines recommend a 30 to 50% increase of the preconceptional levothyroxine dose in women with hypothyroidism, when pregnancy is diagnosed. METHODS A 33 year-old, 8-week pregnant woman with hypothyroidism, presents with a 2-week history of palpitations, sweating, nervousness and fatigue. Physical examination shows tachycardia (108 bpm), distal tremors and diffuse goiter. After biochemical confirmation of hyperthyroidism, her levothyroxine dose is reduced and finally interrupted. Propylthiouracil is started and maintained until after the delivery of a healthy baby at week 40. Two weeks postpartum, hyperthyroidism worsens and propylthiouracil is replaced by methimazole. Eighteen months after delivery 7.5 mCi 131Iodine was given. Two months later, hypothyroidism developed and levothyroxine was initiated. CONCLUSIONS Although conversion of Hashimoto's hypothyroidism into Graves' disease is exceptional in pregnancy, pregnant women with autoimmune hypothyroidism should ideally have their TSH concentrations measured before empirically increasing their levothyroxine dose.

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
January 2022, Clinical endocrinology,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
June 1996, Australian and New Zealand journal of medicine,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
October 1973, Ginekologia polska,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
January 2012, International journal of clinical and experimental medicine,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
August 2022, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
July 2005, Thyroid : official journal of the American Thyroid Association,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
November 2012, Nihon rinsho. Japanese journal of clinical medicine,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
February 1970, JAMA,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
July 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
María Alberiche, and Rosa María Sánchez-Hernández, and Xabier López Mérida, and Ana María Wägner
April 2012, Ginekologia polska,
Copied contents to your clipboard!